Varenicline (Champix) and bupropion (Zyban) are not associated with serious adverse cardiovascular and neuropsychiatric events in smokers with COPD, according to a recent study (Thorax 2017; doi:10.1136/thoraxjnl-2017-210067).
Both drugs are effective smoking cessation treatments, but there have been concerns about their safety in smokers with COPD.
Items tagged as: smoking
41% of men and 31% of women are ‘overweight’ and 27% are ‘obese’ according to the Health Survey for England 2015.
The survey, carried out since 1994, quizzed over 13 000 adults and children on a range of health issues through interviews and nurse visits.
The number …